SCHAERR JAFFE LLP

Lobbying for CELLPHIRE THERAPEUTICS, INC. · biotechnology company

Filing Registration

3rd Quarter (July 1 - Sep 30) 2025 · Maryland · posted Jul 25, 2025

Lobbying activity 2

Health Issues

Increasing and improving the nation's blood platelet supply.

Disaster Planning/Emergencies

Increasing and improving the nation's blood platelet supply.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.